The influence of desalivation and age on susceptibility to infection by Streptococcus sobrinus was studied using 80 Sprague-Dawley female rats weaned at age 21 days. Forty animals (donors) were infected with S. sobrinus 6715 (ATCC 27352), formed into ten groups of 4, fed diet 2000, and offered 10% sucrose water ad libitum. The remaining 40 animals were fed laboratory chow and sterile distilled water until introduced into the experiment. When the animals were aged 25 days, 10 noninfected animals were anesthetized, desalivated, and caged with 10 infected (donor) animals (group I). On day 36 these procedures were repeated on the remaining animals (group II). Infection was checked daily. Animals were regarded as infected when S. sobrinus was detected on 2 consecutive days and confirmed 1 week later. Animals were killed, jaws dissected, and populations of S. sobrinus and total bacterial viable count of each jaw estimated. The average number of days from pairing to detecting infection (2 consecutive days) was as follows: group I (age 25 days): desalivated 5.4 (SD 2.5), intact 8.8 (SD 4.5); group II (age 36 days): desalivated 7.8 (SD 2.9). Only 3 intact animals became infected in group II after a total elapsed time of 21 days. The mean viable counts of S. sobrinus per jaw in group I were as follows: desalivated 3.6 × 106 (SD 4.1); donor cagemate 13.0 × 106 (SD 9.7); intact 0.26 × 106 (SD 0.39); donor cagemate 4.5 × 106 (SD 4.3). Desalivated animals tended to be more heavily infected than intact animals. The results showed that desalivated animals (25 or 36 days) were more susceptible to infection by S. sobrinus, and susceptibility to infection decreased with age. The data presented here could have implications for hyposalivatory humans and for their cohorts in their immediate environment.

Keywords:
Aging, Desalivation, Infection, Streptococcus sobrinus
This content is only available via PDF.
© 1989 S. Karger AG, Basel
1989
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.